These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34172566)

  • 1. Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease.
    Zhang S; Liu YQ; Jia C; Lim YJ; Feng G; Xu E; Long H; Kimura Y; Tao Y; Zhao C; Wang C; Liu Z; Hu JJ; Ma MR; Liu Z; Jiang L; Li D; Wang R; Dawson VL; Dawson TM; Li YM; Mao X; Liu C
    Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34172566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein.
    Mao X; Gu H; Kim D; Kimura Y; Wang N; Xu E; Kumbhar R; Ming X; Wang H; Chen C; Zhang S; Jia C; Liu Y; Bian H; Karuppagounder SS; Akkentli F; Chen Q; Jia L; Hwang H; Lee SH; Ke X; Chang M; Li A; Yang J; Rastegar C; Sriparna M; Ge P; Brahmachari S; Kim S; Zhang S; Shimoda Y; Saar M; Liu H; Kweon SH; Ying M; Workman CJ; Vignali DAA; Muller UC; Liu C; Ko HS; Dawson VL; Dawson TM
    Nat Commun; 2024 May; 15(1):4663. PubMed ID: 38821932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.
    Mao X; Ou MT; Karuppagounder SS; Kam TI; Yin X; Xiong Y; Ge P; Umanah GE; Brahmachari S; Shin JH; Kang HC; Zhang J; Xu J; Chen R; Park H; Andrabi SA; Kang SU; Gonçalves RA; Liang Y; Zhang S; Qi C; Lam S; Keiler JA; Tyson J; Kim D; Panicker N; Yun SP; Workman CJ; Vignali DA; Dawson VL; Ko HS; Dawson TM
    Science; 2016 Sep; 353(6307):. PubMed ID: 27708076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM.
    Zhao K; Lim YJ; Liu Z; Long H; Sun Y; Hu JJ; Zhao C; Tao Y; Zhang X; Li D; Li YM; Liu C
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20305-20315. PubMed ID: 32737160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.
    Ghanem SS; Majbour NK; Vaikath NN; Ardah MT; Erskine D; Jensen NM; Fayyad M; Sudhakaran IP; Vasili E; Melachroinou K; Abdi IY; Poggiolini I; Santos P; Dorn A; Carloni P; Vekrellis K; Attems J; McKeith I; Outeiro TF; Jensen PH; El-Agnaf OMA
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2109617119. PubMed ID: 35353605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils.
    Tavassoly O; Yue J; Vocadlo DJ
    FEBS J; 2021 Jan; 288(2):452-470. PubMed ID: 32365408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P; Bhat R
    ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.
    Nahass GR; Sun Y; Xu Y; Batchelor M; Reilly M; Benilova I; Kedia N; Spehar K; Sobott F; Sessions RB; Caughey B; Radford SE; Jat PS; Collinge J; Bieschke J
    J Mol Biol; 2021 Apr; 433(8):166878. PubMed ID: 33610557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease.
    Gustot A; Gallea JI; Sarroukh R; Celej MS; Ruysschaert JM; Raussens V
    Biochem J; 2015 Nov; 471(3):323-33. PubMed ID: 26272943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
    Samuel F; Flavin WP; Iqbal S; Pacelli C; Sri Renganathan SD; Trudeau LE; Campbell EM; Fraser PE; Tandon A
    J Biol Chem; 2016 Feb; 291(9):4374-85. PubMed ID: 26719332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
    McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
    J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.
    Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining an amyloid link Between Parkinson's disease and melanoma.
    Dean DN; Lee JC
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22671-22673. PubMed ID: 32868414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
    Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
    J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation.
    Lu J; Zhang S; Ma X; Jia C; Liu Z; Huang C; Liu C; Li D
    J Biol Chem; 2020 May; 295(21):7470-7480. PubMed ID: 32291284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.
    Zaidi FK; Deep S
    Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.
    Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA
    Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
    Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
    J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.